This is the authors' abstract. We don't add key points for this paper.
Based on these results, the present UHPLC-MS/MS method can be considered suitable for routine TDM of teicoplanin. Also, based on the insufficient trough teicoplanin concentrations achieved with standard dose regimen, and the higher trough teicoplanin concentrations achieved with TDM-guided individualized dose regimen, this study highlights the importance of TDM of teicoplanin, especially in high-risk patient groups.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chae et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: